EY Acquires Aqurance to Expand Veeva Technology Services for Life Sciences
EY has acquired Greek Veeva services partner Aqurance to enhance its Veeva Centers of Excellence and expand its clinical, regulatory, and commercial service capabilities for life sciences companies, announced in a press release.
Aqurance, a recognized Veeva Premier Services Partner for Commercial Cloud and Services Partner for Development Cloud, provides consulting across Veeva applications used in both commercial and R&D operations. The acquisition will combine EY’s regulatory, business design, and technology integration expertise with Aqurance’s experience in Veeva Vault and related applications.
The integration aims to help pharmaceutical and biotech clients improve efficiency and compliance through unified Veeva platforms, supporting transitions to Vault CRM and broader digital transformation. EY stated that the combined capabilities will enable life sciences organizations to use data and AI more effectively across their operations.
Following the acquisition, EY Aqurance will participate as a platinum sponsor at the Veeva Commercial Summit in Madrid on November 5–6, 2025.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Nov 12 Octave Acquires Cerebre for Industrial AI Plant Models Nov 11 StitchStudio raises $8M for insurance AI products Nov 11 Stage 2 Capital Closes $100 Million for B2B AI Investments Nov 11 Enza Capital secures $21 million for African AI fund Nov 11 Goldman Sachs Forecasts Anthropic Revenue of $685 Billion by 2030More from Life Sciences
Nov 11 Optum and Alameda Alliance Partner on AI Claims Automation Nov 11 Mosaic Raises $47M for Blood Vessel Surgery Robots Nov 11 Kardi AI Raises €5.3 Million for Heart Monitoring Expansion Nov 11 Switchpoint Bio raises $5.3 million for AI epigenomics platform Nov 10 Google Cloud Launches Gemini for Healthcare With HCA, Northwell and OptumAI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Voya Selects UnqorkAI for Retirement Experiences
AstraZeneca and Oracle Partner on AI for Clinical Trials
Emergys and Glean Partner on Enterprise AI Agents
Trinity Acquires Verix to Add Tovana to TrinityEDGE
Verisk Adds Insurance Data to Amazon Quick, Copilot and Claude
Daily AI Brief: the AI news that matters, in your inbox.